Drugs / pGM169/GL67A
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01621867 Comparator | May 2012 → May 2014 | cystic fibrosis | Imperial College London | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | pGM169/GL67A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01621867 ↗ |
| Modality | Other / unclassified | “Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis” PMID 26149841 ↗ Jul 2015 |
| Route | Inhaled | “5ml Gene Product/Lipid Vector pGM169/GL67A nebulised” NCT01621867 ↗ |